Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYTO

Altamira Therapeutics (CYTO) Stock Price, News & Analysis

Altamira Therapeutics logo

About Altamira Therapeutics Stock (NASDAQ:CYTO)

Advanced Chart

Key Stats

Today's Range
$0.30
$0.43
50-Day Range
$0.30
$0.52
52-Week Range
$0.30
$1.53
Volume
753,013 shs
Average Volume
328,603 shs
Market Capitalization
$1.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYTO Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Altamira Therapeutics Ltd. (CYTOF)
Altamira Therapeutics Ltd (CYTOF)
See More Headlines

CYTO Stock Analysis - Frequently Asked Questions

Altamira Therapeutics shares reverse split before market open on Wednesday, December 13th 2023.The 1-20 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, December 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Altamira Therapeutics investors own include Plug Power (PLUG), Aridis Pharmaceuticals (ARDS), Soligenix (SNGX), Chemomab Therapeutics (CMMB), CNS Pharmaceuticals (CNSP), Cara Therapeutics (CARA) and Draganfly (DPRO).

Company Calendar

Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYTO
CIK
1601936
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.43
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$320 thousand
Price / Sales
3.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.56 per share
Price / Book
0.07

Miscellaneous

Outstanding Shares
3,400,000
Free Float
2,958,000
Market Cap
$1.02 million
Optionable
Not Optionable
Beta
1.80
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:CYTO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners